Clinical trial
A Study of Children With Refractory or Relapsed ALL
NCT00187083 · St. Jude Children's Research Hospital, Other · Completed
Key facts
| NCT number | NCT00187083 |
|---|---|
| Title | A Study of Children With Refractory or Relapsed ALL |
| Official title | A Study of Children With Refractory or Relapsed Acute Lymphoblastic Leukemia (ALLR16) |
| Lead sponsor | St. Jude Children's Research Hospital, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Acute Lymphoblastic Leukemia |
| Intervention type | Drug, Procedure |
| Interventions | Topotecan, dexamethasone, vincristine, E. coli Asparaginase, PEG-L-asparaginase, erwinia asparaginase, fludarabine, methotrexate, mercaptopurine, idarubicin and 6 more |
| Enrollment | 40 |
| Start date | Feb 1, 1997 |
| Primary completion | Dec 1, 2003 |
| Completion | Dec 1, 2003 |
| First posted | Sep 16, 2005 |
| Last update posted | Jun 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: